RAYS OF BELIEF LIMITED vs SUN PHARMACEUTICAL IND L

A side-by-side comparison of RAYS OF BELIEF LIMITED (MOMSBELIEF) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads MOMSBELIEF vs SUNPHARMA on 8 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability22
  • Growth· not comparable
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

SUNPHARMA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

96.30
P/E ratio
38.47
3.01
P/B ratio
20.07
0.00%
Dividend yield
0.84%
₹2.35
EPS
₹47.84

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

16.10%
Return on equity
16.00%
21.47%
Return on capital
21.00%
0.00%
EBITDA margin
28.00%
0.00%
Net margin
19.69%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
10.03%
Profit CAGR (3Y) even
10.57%

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹453 Cr
Market cap
₹4.42L Cr
₹0 Cr
Revenue
₹58,462 Cr
₹0 Cr
Net profit
₹11,509 Cr
0.30
Debt / equity
0.61
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
RAYS OF BELIEF LIMITED full analysis SUN PHARMACEUTICAL IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

MOMSBELIEF vs SUNPHARMA: Share Price, Valuation & Which to Buy | DocStoX